These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tpl2 is a key mediator of arsenite-induced signal transduction. Lee KM; Lee KW; Bode AM; Lee HJ; Dong Z Cancer Res; 2009 Oct; 69(20):8043-9. PubMed ID: 19808956 [TBL] [Abstract][Full Text] [Related]
6. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis. Acuff NV; Li X; Kirkland R; Nagy T; Watford WT PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948 [TBL] [Abstract][Full Text] [Related]
8. Tumor progression locus 2 mediates signal-induced increases in cytoplasmic calcium and cell migration. Hatziapostolou M; Koukos G; Polytarchou C; Kottakis F; Serebrennikova O; Kuliopulos A; Tsichlis PN Sci Signal; 2011 Aug; 4(187):ra55. PubMed ID: 21868363 [TBL] [Abstract][Full Text] [Related]
9. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages. Loniewski KJ; Patial S; Parameswaran N Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of miR-144 after Mycobacterium tuberculosis infection promotes inflammatory factor secretion from macrophages through the Tpl2/ERK pathway. Liu HY Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):87-93. PubMed ID: 26950457 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity. Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217 [TBL] [Abstract][Full Text] [Related]
12. Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor-induced TIMP-1 gene transcription in hepatic stellate cells in mice. Perugorria MJ; Murphy LB; Fullard N; Chakraborty JB; Vyrla D; Wilson CL; Oakley F; Mann J; Mann DA Hepatology; 2013 Mar; 57(3):1238-49. PubMed ID: 23080298 [TBL] [Abstract][Full Text] [Related]
13. The role of tumor progression locus 2 protein kinase in glial inflammatory response. Hirschhorn J; Mohanty S; Bhat NR J Neurochem; 2014 Mar; 128(6):919-26. PubMed ID: 24188160 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide. Cho J; Tsichlis PN Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2350-5. PubMed ID: 15699325 [TBL] [Abstract][Full Text] [Related]
15. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation. Sugimoto K; Ohata M; Miyoshi J; Ishizaki H; Tsuboi N; Masuda A; Yoshikai Y; Takamoto M; Sugane K; Matsuo S; Shimada Y; Matsuguchi T J Clin Invest; 2004 Sep; 114(6):857-66. PubMed ID: 15372110 [TBL] [Abstract][Full Text] [Related]
16. Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice. Gong J; Fang C; Zhang P; Wang PX; Qiu Y; Shen LJ; Zhang L; Zhu XY; Tian S; Li F; Wang Z; Huang Z; Wang A; Zhang XD; She ZG Hepatology; 2019 Feb; 69(2):524-544. PubMed ID: 29381809 [TBL] [Abstract][Full Text] [Related]
17. Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer. Lee HW; Choi HY; Joo KM; Nam DH Int J Mol Sci; 2015 Feb; 16(3):4471-91. PubMed ID: 25723737 [TBL] [Abstract][Full Text] [Related]
18. Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity. Njunge LW; Estania AP; Guo Y; Liu W; Yang L Theranostics; 2020; 10(18):8343-8364. PubMed ID: 32724474 [TBL] [Abstract][Full Text] [Related]
19. NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Waterfield MR; Zhang M; Norman LP; Sun SC Mol Cell; 2003 Mar; 11(3):685-94. PubMed ID: 12667451 [TBL] [Abstract][Full Text] [Related]
20. IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2. Handoyo H; Stafford MJ; McManus E; Baltzis D; Peggie M; Cohen P Biochem J; 2009 Oct; 424(1):109-18. PubMed ID: 19754427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]